GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cambium Bio Ltd (ASX:CMB) » Definitions » Non Operating Income

Cambium Bio (ASX:CMB) Non Operating Income : A$0.72 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cambium Bio Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Cambium Bio's Non Operating Income for the six months ended in Dec. 2024 was A$0.55 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.72 Mil.

Cambium Bio Non Operating Income Historical Data

The historical data trend for Cambium Bio's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambium Bio Non Operating Income Chart

Cambium Bio Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.15

Cambium Bio Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.33 0.17 0.55

Cambium Bio Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambium Bio Non Operating Income Related Terms

Thank you for viewing the detailed overview of Cambium Bio's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cambium Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cambium Bio Ltd (ASX:CMB) » Definitions » Non Operating Income
Comparable Companies
ASX:IXC ASX:BGT ASX:PAB ASX:VBS ASX:ZLD ASX:BIT ASX:1AD ASX:NSB ASX:CHM ASX:1AI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
16 Goodhope Street, Paddington, Sydney, NSW, AUS, 2021
Website
https://www.cambium.bio
Cambium Bio Ltd is a clinical-stage regenerative medicine company in Australia. It focuses on the development of biologics for ophthalmology and tissue repair applications. Its technology platform is based on human platelet lysate, which is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. The company's product candidate Elate Ocular is being developed to address unmet medical needs in the treatment of dry eye disease. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications.

Cambium Bio Headlines

No Headlines